370 related articles for article (PubMed ID: 22566575)
1. Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
Kunnen S; Van Eck M
J Lipid Res; 2012 Sep; 53(9):1783-99. PubMed ID: 22566575
[TBL] [Abstract][Full Text] [Related]
2. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
Calabresi L; Franceschini G
Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
[TBL] [Abstract][Full Text] [Related]
3. A review on lecithin:cholesterol acyltransferase deficiency.
Saeedi R; Li M; Frohlich J
Clin Biochem; 2015 May; 48(7-8):472-5. PubMed ID: 25172171
[TBL] [Abstract][Full Text] [Related]
4. The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks - a clinical update and emerging insights from animal models.
Ng DS
Biochim Biophys Acta; 2012 Apr; 1821(4):654-9. PubMed ID: 22326749
[TBL] [Abstract][Full Text] [Related]
5. Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiency.
Savel J; Lafitte M; Pucheu Y; Pradeau V; Tabarin A; Couffinhal T
Vasc Health Risk Manag; 2012; 8():357-61. PubMed ID: 22701329
[TBL] [Abstract][Full Text] [Related]
6. Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?
Rousset X; Shamburek R; Vaisman B; Amar M; Remaley AT
Curr Atheroscler Rep; 2011 Jun; 13(3):249-56. PubMed ID: 21331766
[TBL] [Abstract][Full Text] [Related]
7. Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport.
Dobiásová M; Frohlich JJ
Clin Chim Acta; 1999 Aug; 286(1-2):257-71. PubMed ID: 10511297
[TBL] [Abstract][Full Text] [Related]
8. BacMam production of active recombinant lecithin-cholesterol acyltransferase: Expression, purification and characterization.
Romanow WG; Piper DE; Fordstrom P; Thibault S; Zhou M; Walker NP
Protein Expr Purif; 2016 Sep; 125():1-6. PubMed ID: 26363122
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
[TBL] [Abstract][Full Text] [Related]
10. LCAT- targeted therapies: Progress, failures and future.
Yang K; Wang J; Xiang H; Ding P; Wu T; Ji G
Biomed Pharmacother; 2022 Mar; 147():112677. PubMed ID: 35121343
[TBL] [Abstract][Full Text] [Related]
11. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma cholesterol esterification by LCAT reduces diet-induced atherosclerosis in SR-BI knockout mice.
Thacker SG; Rousset X; Esmail S; Zarzour A; Jin X; Collins HL; Sampson M; Stonik J; Demosky S; Malide DA; Freeman L; Vaisman BL; Kruth HS; Adelman SJ; Remaley AT
J Lipid Res; 2015 Jul; 56(7):1282-95. PubMed ID: 25964513
[TBL] [Abstract][Full Text] [Related]
13. Novel LCAT (Lecithin:Cholesterol Acyltransferase) Activator DS-8190a Prevents the Progression of Plaque Accumulation in Atherosclerosis Models.
Sasaki M; Delawary M; Sakurai H; Kobayashi H; Nakao N; Tsuru H; Fukushima Y; Honzumi S; Moriyama S; Wada N; Kaneko T; Yamada K; Terasaka N; Kubota K
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):360-376. PubMed ID: 33086872
[TBL] [Abstract][Full Text] [Related]
14. Catalytically inactive lecithin: cholesterol acyltransferase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiency.
Yang XP; Inazu A; Honjo A; Koizumi I; Kajinami K; Koizumi J; Marcovina SM; Albers JJ; Mabuchi H
J Lipid Res; 1997 Mar; 38(3):585-91. PubMed ID: 9101439
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous Atherosclerosis in Aged LCAT-Deficient Hamsters With Enhanced Oxidative Stress-Brief Report.
Guo M; Liu Z; Xu Y; Ma P; Huang W; Gao M; Wang Y; Liu G; Xian X
Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):2829-2836. PubMed ID: 32998519
[TBL] [Abstract][Full Text] [Related]
16. Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis.
Santamarina-Fojo S; Lambert G; Hoeg JM; Brewer HB
Curr Opin Lipidol; 2000 Jun; 11(3):267-75. PubMed ID: 10882342
[TBL] [Abstract][Full Text] [Related]
17. Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.
Tanigawa H; Billheimer JT; Tohyama J; Fuki IV; Ng DS; Rothblat GH; Rader DJ
Circulation; 2009 Jul; 120(2):160-9. PubMed ID: 19564558
[TBL] [Abstract][Full Text] [Related]
18. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
Calabresi L; Simonelli S; Conca P; Busnach G; Cabibbe M; Gesualdo L; Gigante M; Penco S; Veglia F; Franceschini G
J Intern Med; 2015 May; 277(5):552-61. PubMed ID: 25039266
[TBL] [Abstract][Full Text] [Related]
19. Role of LCAT in Atherosclerosis.
Ossoli A; Simonelli S; Vitali C; Franceschini G; Calabresi L
J Atheroscler Thromb; 2016; 23(2):119-27. PubMed ID: 26607351
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice.
Vaisman BL; Klein HG; Rouis M; Bérard AM; Kindt MR; Talley GD; Meyn SM; Hoyt RF; Marcovina SM; Albers JJ
J Biol Chem; 1995 May; 270(20):12269-75. PubMed ID: 7744879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
